ADVI’s Lindsay Bealor Greenleaf talked to Pharmacy Times about the role of the federal government in drug pricing & how the Build Back Better Act would impact it moving forward
ADVI’s Lindsay Bealor Greenleaf talked to Pharmacy Times about the role of the federal government in drug pricing & how the Build Back Better Act would impact it moving forward. Read the full article here
Reach out
Own your edge
We don’t just guide the market. We shape it. Map your market access moves with #ADVIIntelligence. Proven advantage. Unmatched partnership.